B2BROKER
B2Broker , a leading liquidity and technology provider of solutions to the forex and crypto industry, is pleased to announce it has launched its new website and new corporate branding. This is the company’s first major website and corporate identity update and is aligned with its expansion plans to position itself as the leading global provider in its genre, having secured over 200 institutional customers to date.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201020005105/en/
Rationale
While the last few months have presented a challenging situation regarding the Covid-19 global pandemic, B2Broker noted the increases in online trading which impacted on demand for Forex and crypto-related services from brokerages. The situation served as an important trigger to move forward with the new website and branding project to provide current and potential clients access to encyclopedic information and a new experience that is an industry first.
The rationale is summed up by B2Broker Chief Operating Officer, Evgeniya Mykulyak. “We created the previous version of our website two years ago and a lot has since changed…over the course of a year, 15 team members set out to build the best website in the industry, which would not only reflect the full essence of our products, but also provide general information about the industry. Our new logo meanwhile, reflects new values and meanings that are really close to the heart of our company, our team and our products.”
New Branding
The new brand strategy involves the use of 9 circles representing the 9 product groups with the circles depicting the products being perfectly formed like circles, allowing clients to build their business like a jigsaw using the company’s products. The square surrounding the image reflects the security and stability of the company’s products, whilst the colour green represents profitability and margin and the shades - market growth and vitality.
Rollout
The new B2Broker website which has been released in 8 languages officially launched on 14th October, 2020 with clients now being referred to the new domain www.b2broker.com
Arthur Azizov, CEO B2Broker, added, “B2Broker is now in its 6th year of successful operations and our new website and branding is an important milestone in the company’s growth and development. Our newly introduced branding reflects our prime position in the industry, the breadth of technology and liquidity services we offer and the global nature of our operations. This is an exciting company with even bigger plans for the market, and now we have a state-of-the-art website and more distinctive brand that fully expresses our purpose.
About B2Broker
B2Broker’s range of products and services include: Cryptocurrency Liquidity , Forex Liquidity , CFD Liquidity , Forex Broker Turnkey , Crypto Broker Turnkey , Crypto Payment Gateway , B2Core (Trader’s Room and Back Office Software), Investment Platform , MT4 / MT5 White Label solutions , Cryptocurrency Exchange Development and www.b2bx.exchange , all of which contribute to the company’s growing presence across the globe.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201020005105/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Australian Defence Force Secures Satellite Communications on SES IS-2212.1.2026 22:30:00 CET | Press release
New agreement for uninterrupted UHF connectivity for Australian Defence Force through 2033, With Options Extending to 2041 Satellite communications solutions provider SES will provide secure uninterrupted satellite communications to the Australian Defence Force (ADF) for a minimum of 16 years thanks to a new extended agreement. The service will be provided via the SES Intelsat 22 satellite and an ultra-high frequency (UHF) military communications payload. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112137182/en/ Assistant Secretary Space Systems Branch, Michael Hunt, formalizes contract negotiations for the through-life support of the IS-22 satellite with Rory Welch, senior vice-president of service delivery at SES Space and Defense. Photos: Corporal Annika Smit Under the renewed arrangement, SES will reposition the IS-22 satellite to a new orbital slot specified by the ADF, continuing a mission that has been the corne
NetApp Appoints Paul Fipps to the Board of Directors12.1.2026 22:05:00 CET | Press release
NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced that Paul Fipps, President of Global Customer Operations at ServiceNow, has joined its Board of Directors. The board now has ten directors, nine of whom are independent, and 50% of whom have been appointed within the last five years. Fipps brings more than 20 years of experience driving technology-enabled growth and customer transformation. At ServiceNow, he currently leads global sales, customer success, partner ecosystems, and field operations. He previously served as EVP of Worldwide Sales at ServiceNow and as President of Under Armour Connected Fitness and Chief Experience Officer at Under Armour, overseeing global direct-to-consumer, connected fitness, and digital experiences. He also previously served on the advisory board of Quantum Metric. Fipps holds a B.S. in Information Systems, an MBA from the University of Baltimore, and is a graduate of The Wharton School’s Advanced Management Program. “P
FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor12.1.2026 20:00:00 CET | Press release
Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s new drug application (NDA) for pimicotinib as a systemic treatment for patients with tenosynovial giant cell tumor (TGCT). The application is based on the primary results and longer-term follow-up of the global Phase 3 MANEUVER study, which demonstrated deep and durable tumor responses and meaningful improvements in clinical outcomes with pimicotinib. “With pimicotinib, we have an opportunity to significantly advance care for people living with TGCT, a painful and debilitating disease that has few effective and well-tolerated treatment options beyond surgery,” said David Weinreich, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “Based on clinical trial results showing not only a reduction in tumor burden, but also the ability to help alleviate symptoms like pain an
Fabentech receives Marketing Authorization for Ricimed®, an antidote against ricin poisoning12.1.2026 19:32:00 CET | Press release
First Marketing Authorization granted in France for the treatment of ricin poisoning, one of the most toxic natural substances in the world and a recognized priority biological threat. Ricimed® addresses a previously unmet medical need in the management of severe and potentially fatal ricin intoxications.Supported by the French Ministry of the Armed Forces and Veterans Affairs (the Directorate General of Armaments and the French Military Health Service), the development of Ricimed® illustrates Fabentech’s transition to a new scale and, with recent support from the European HERA Invest program, reinforces its positioning as a reference player in medical countermeasures against biological threats, serving both civilian and military markets. Fabentech, a French biopharmaceutical company specializing in medical countermeasures against biological threats, today announces that it has been granted Marketing Authorization for Ricimed®, a treatment for ricin poisoning. This press release featur
Traxys Group and the Shareholders of Comax2 AB - the holding company of Carbomax AB - sign Share Purchase Agreement to sell 100% interests to Traxys Group12.1.2026 19:20:00 CET | Press release
Traxys S.à.r.l., Investment Aktiebolaget Spiltan and other major shareholders of Comax 2 AB – the holding company of Carbomax AB –are pleased to announce that they have signed a Share Purchase Agreement (SPA) to sell 100% interests to Traxys Group. Carbomax AB is a leading Swedish trading house and industrial operator specializing in ferroalloys, carbon products and briquettes. The transaction aims to strengthen Traxys’ presence in the Scandinavian market and support the region’s transition toward sustainable steel production. Closing of the transaction is expected to occur in the first quarter 2026 following clearance by Swedish authorities, including foreign direct investment and antitrust approvals. Carbomax serves regional steel plants and most of foundries across the Nordics. With its strategic location near Västerås harbor and integrated processing capabilities Carbomax is well-positioned to capitalize on growing demand for green steel and sustainable raw materials. Mark Kristoff
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom